Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × Advanced Solid Malignancy, × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1350 Carcinoma, Non-Small-Cell Lung 659 Breast Neoplasms 507 Neoplasm Metastasis 463 Colorectal Neoplasms 377 Melanoma 348 Leukemia, Myeloid, Acute 329 Multiple Myeloma 323 Ovarian Neoplasms 311 Lymphoma 305 Recurrence 301 Advanced Solid Tumors 284 Lymphoma, Non-Hodgkin 274 Prostatic Neoplasms 261 Pancreatic Neoplasms 242 Advanced Solid Tumor 213 Carcinoma, Renal Cell 201 Stomach Neoplasms 199 Solid Tumor 186 Squamous Cell Carcinoma of Head and Neck 183 Lung Neoplasms 180 Leukemia, Lymphocytic, Chronic, B-Cell 175 Triple Negative Breast Neoplasms 159 Solid Tumors 158 Carcinoma, Hepatocellular 141 Hematologic Neoplasms 138 Lymphoma, Large B-Cell, Diffuse 132 Head and Neck Neoplasms 131 Lymphoma, Follicular 129 Myelodysplastic Syndromes 126

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01895946 2016-05-25

OAK

AstraZeneca

Phase 1 Completed

33 enrolled 14 charts

Advanced Solid Malignancy,

Data powered by HemOnc (CC BY 4.0) Colophon ⚡